Hypoxia-induced VEGF production 'RSUMEs' in pituitary adenomas

Endocrine-Related Cancer

Volumn 19, Issue 1, 2012, Pages

  Fowkes, RobertC ^a   Vlotides, George ^b  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROTEIN; RSUME PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN; RSUME PROTEIN, HUMAN; TRANSCRIPTION FACTOR; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANGIOGENESIS; CARCINOGENESIS; CELL SURVIVAL; HORMONE RELEASE; HUMAN; HYPOPHYSIS ADENOMA; HYPOXIA; NOTE; PROTEIN EXPRESSION; SUMOYLATION; ADENOMA; ANIMAL; ANOXIA; ARTICLE; HYPOPHYSIS TUMOR; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY;

ADENOMA; ANIMALS; ANOXIA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOVASCULARIZATION, PATHOLOGIC; PITUITARY NEOPLASMS; TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84860321278     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-11-0297     Document Type: Note

References (16)

1. Carbia-Nagashima A, Gerez J, Perez-Castro C, Paez-Pereda M, Silberstein S, Stalla GK, Holsboer F & Arzt E 2007 RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1alpha during hypoxia. Cell 131 309-323. (doi:10.1016/j.cell.2007.07.044)
2. Castro CP, Giacomini D, Nagashima AC, Onofri C, Graciarena M, Kobayashi K, Páez-Pereda M, Renner U, Stalla GK & Arzt E 2003 Reduced expression of the cytokine transducer gp130 inhibits hormone secretion, cell growth, and tumor development of pituitary lactosomatotrophic GH3 cells. Endocrinology 144 693-700. (doi:10.1210/en.2002-220891)
3. Ferrara N 2004 Vascular endothelial growth factor: basic science and clinical progress. Endocrine Reviews 25 581-611. (doi:10.1210/er.2003-0027)
4. Gloddek J, Pagotto U, Paez Pereda M, Arzt E, Stalla GK & Renner U 1999 Pituitary adenylate cyclase-activating polypeptide, interleukin-6 and glucocorticoids regulate the release of vascular endothelial growth factor in pituitary folliculostellate cells. Journal of Endocrinology 160 483-490. (doi:10.1677/joe.0.1600483)
5. Kim K, Yoshida D & Teramoto A 2005 Expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in pituitary adenomas. Endocrine Pathology 16 115-121. (doi:10.1385/EP:16:2:115)
6. Luque GM, Perez-Millán MI, Ornstein AM, Cristina C & Becu-Villalobos D 2011 Inhibitory effects of antivascular endothelial growth factor strategies in experimental dopamine-resistant prolactinomas. Journal of Pharmacology and Experimental Therapeutics 337 766-774. (doi:10.1124/jpet.110. 177790)
7. McCabe CJ, Boelaert K, Tannahill LA, Heaney AP, Stratford AL, Khaira JS, Hussain S, Sheppard MC, Franklyn JA & Gittoes NJ 2002 Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors. Journal of Clinical Endocrinology and Metabolism 87 4238-4244. (doi:10.1210/jc.2002-020309)
8. Melmed S 2011 Pathogenesis of pituitary tumors. Nature Reviews. Endocrinology 7 257-266. (doi:10.1038/nrendo.2011.40)
9. Onofri C, Theodoropoulou M, Losa M, Uhl E, Lange M, Arzt E, Stalla GK & Renner U 2006 Localization of vascular endothelial growth factor (VEGF) receptors in normal and adenomatous pituitaries: detection of a non-endothelial function of VEGF in pituitary tumours. Journal of Endocrinology 191 249-261. (doi:10.1677/joe.1.06992)
10. Renner U, De Santana EC, Gerez J, Fröhlich B, Haedo M, Pereda MP, Onofri C, Stalla GK & Arzt E 2009 Intrapituitary expression and regulation of the gp130 cytokine interleukin-6 and its implication in pituitary physiology and pathophysiology. Annals of the New York Academy of Sciences 1153 89-97. (doi:10.1111/j.1749-6632.2008.03970.x)
11. Shan B, Gerez J, Haedo M, Fuertes M, Theodoropoulou M, Buchfelder M, Losa M, Stalla GK, Arzt E & Renner U RSUME is implicated in HIF-1-induced VEGF-A production in pituitary tumour cells. Endocrine-Related Cancer 19 13-27. (doi:10.1530/ERC-11-0211)
12. Turner HE, Nagy Z, Gatter KC, Esiri MM, Harris AL & Wass JA 2000 Angiogenesis in pituitary adenomas and the normal pituitary gland. Journal of Clinical Endocrinology and Metabolism 85 1159-1162. (doi:10.1210/jc.85.3.1159)
13. Vidal S, Scheithauer BW & Kovacs K 2000 Vascularity in nontumorous human pituitaries and incidental microadenomas: a morphometric study. Endocrine Pathology 11 215-227. (doi:10.1385/EP:11:3:215)
14. Vidal S, Kovacs K, Horvath E, Scheithauer BW, Kuroki T & Lloyd RV 2001 Microvessel density in pituitary adenomas and carcinomas. Virchows Archiv: an International Journal of Pathology 438 595-602. (doi:10.1007/s004280000373)
15. Yoshida D, Kim K, Noha M & Teramoto A 2006 Anti-apoptotic action by hypoxia inducible factor 1-alpha in human pituitary adenoma cell line, HP-75 in hypoxic condition. Journal of Neuro-Oncology 78 217-225. (doi:10.1007/s11060- 005-9017-9)
16. Yu R & Melmed S 2010 Pathogenesis of pituitary tumors. Progress in Brain Research 182 207-227. (doi:10.1016/S0079-6123(10)82009-6)